PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ)
$0.69 -0.0273 (-3.8059%)
Analysed PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) News Sources
Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)
20-04-2026
yahoo.com
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
01-04-2026
yahoo.com
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
17-02-2026
yahoo.com
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
13-01-2026
yahoo.com
Insiders Buying Pasithea Therapeutics Might Wish They Invested More, Stock Gains 10%
04-12-2025
yahoo.com
Lawrence Steinman Bought 201% More Shares In Pasithea Therapeutics
04-12-2025
yahoo.com
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
02-12-2025
yahoo.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
01-12-2025
yahoo.com
US Equity Markets Close Higher During Thanksgiving Week as Interest Rate Cut Expectations Remain Strong
28-11-2025
yahoo.com
BC-Most Active Stocks
28-11-2025
yahoo.com
What is the current price of PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ)?
The current price of PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) is $0.69.
PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) since the previous trading day is $-0.0273.
PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) since the previous trading day is -3.8059%.
What is the most recent average sentiment score for PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ)?
The most recent average sentiment score for PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ)?
The most recent sentiment for PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ) is .
SEC-8K** Filing Available For PASITHEA THERAPEUTICS CORP (KTTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.